2023 Annual Meeting of the American Society for Investigative Pathology

2023年美国调查病理学学会（ASIP）年会将与 10月22日至25日在索尔特的美国大酒店举行的组织、基质和病理学会议上， 犹他州湖城。这次科学会议是组织化学学会，美国 矩阵生物学协会和ASIP。本协会年会提供了一个独特的论坛， 介绍和分享实验病理学的前沿研究。目标受众和主题 会议讨论的问题各不相同，但都以疾病机制为共同重点。反映 为了满足ASIP成员的利益，2023年年会为期四天的科学计划包括 全体会议、主要专题讨论会、颁奖讲座、讲习班、嘉宾社会专题讨论会和特别会议 涵盖疾病发病机制、生物标志物开发、预防、诊断和治疗，先进的 技术、器官系统和系统生物学。这个程序包含了癌症的强成分 病理生物学主要的癌症相关的会议将集中在：（一）癌症代谢，转移，和治疗 意义;（ii）癌症中的转录控制;（iii）组织损伤和癌症生物学-细胞外囊泡 疾病;（iv）乳腺癌和基质之间的交叉;（v）癌症进展和转移。 此外，四个有价值的获奖讲座将有一个癌症的重点：（a）HPV和癌症;（B）多种功能 先天免疫细胞在肠道炎症和癌症中的作用和命运;（c）癌症转移的表观遗传控制 和免疫逃避;和（d）TIMPs：在组织稳态和癌症进展中的新兴作用。 以癌症为重点的研究介绍的其他机会将包括抽象驱动的小对称 以及海报讨论会，其中将有意突出年轻的研究人员和实习科学家。的 该方案还提供了一些侧重于教育和职业发展的会议。这些会议 是专为学员和年轻的研究人员，但开放给所有与会者。教育和职业 2023年的发展主题包括导航具有挑战性的对话，以及增强口头和 视觉沟通技巧。ASIP将促进受训者和年轻人的职业发展 调查员作为年度会议的一个非常重要的方面。因此，会议不提供 只有为他们的需要而设计的特别活动，还有突出/展示他们工作的会议。类似地， 项目委员会努力确保参与者在性别、民族/种族方面的多样性 群体、职业生涯阶段和机构隶属关系。2023年，在受邀演讲者中：39%是女性，39%是 助理/副教授（或同等学历），100%的会议包括发言者是妇女或 代表性不足。这项申请的唯一具体目的是促进学员和青年的参与， 研究人员在2023年年会通过提供奖学金计划，针对毕业生 学生、博士后研究员、临床住院医师/研究员和初级教员。

The 2023 Annual Meeting of the American Society for Investigative Pathology (ASIP), will be held in conjunction with the Tissue, Matrix, and Pathobiology conference from October 22-25 at The Grand America Hotel in Salt Lake City, UT. This scientific conference is a collaboration between The Histochemical Society, the American Society for Matrix Biology, and the ASIP. The Annual Meeting of the ASIP provides a unique forum for presentation and sharing of cutting-edge research in experimental pathology. The target audience and subject matter for the meeting are diverse, but united by a common focus on mechanisms of disease. Reflecting the interests of the ASIP membership, the four-day scientific program for the 2023 Annual Meeting is comprised of plenary sessions, major symposia, award lectures, workshops, guest society symposia, and special sessions covering disease pathogenesis, biomarker development, prevention, diagnosis, and therapeutics, advanced technologies, organ systems, and systems biology. This program contains strong components in cancer pathobiology. Major cancer-related sessions will focus on: (i) Cancer Metabolism, Metastasis, and Therapeutic Implications; (ii) Transcriptional Control in Cancer; (iii) Tissue Injury and Cancer Biology – Extracellular Vesicles in Disease; (iv) The Intersection Between Breast Cancer and the Matrix; (v) Cancer Progression and Metastasis. In addition, four meritorious award lectures will have a cancer-focus: (a) HPV and Cancer; (b) Diverse Functions and Fates of Innate Immune Cells in Gut Inflammation and Cancer; (c) Epigenetic Control of Cancer Metastasis and Immune Evasion; and (d) TIMPs: Emerging Roles in Tissue Homeostasis and Cancer Progression. Additional opportunities for presentation of cancer-focused research will include abstract-driven minisymposia and poster discussion sessions, which will intentionally feature young investigators and trainee scientists. The program further provides a number of sessions focused on education and career development. These sessions are designed for trainees and young investigators, but are open to all attendees. Education and career development topics for 2023 include navigating challenging conversations, and enhancement of verbal and visual communication skills. The ASIP regards promotion of the career development of trainee and young investigators as an extremely important aspect of the Annual Meeting. Accordingly, the meeting provides not only special events designed for their needs, but also sessions that highlight/showcase their work. Similarly, the Program Committee works hard to ensure diversity among the participants with respect to gender, ethnic/racial group, stage of career, and institutional affiliation. For 2023, among invited speakers: 39% are women, 39% are Assistant/Associate Professors (or equivalent), and 100% of sessions include speakers that are women or underrepresented. The sole specific aim of this application is to promote the participation of trainees and young investigators in the 2023 Annual Meeting through provision of a Scholar Award program targeted to graduate students, postdoctoral fellows, clinical residents/fellows, and junior faculty members.